NCT05318027 ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Status COMPLETED Phase NA
NCT05274048 Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients Status RECRUITING Phase PHASE1
NCT05237921 Adherence to Exercise and Dietary Intervention in Cancer Patients Status COMPLETED Phase NA
NCT05226221 Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality Status RECRUITING Phase N/A
NCT05225844 An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal Status UNKNOWN Phase PHASE2
NCT05221320 Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies Status TERMINATED Phase PHASE2
NCT05220046 Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05158907 Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study Status SUSPENDED Phase NA
NCT05141617 Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding Status UNKNOWN Phase NA
NCT05132868 Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling Status COMPLETED Phase NA
NCT05131815 The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors Status COMPLETED Phase NA
NCT05113264 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers Status COMPLETED Phase NA
NCT05053191 Advancing Nursing Practices in Hospital Oncology Care Status ACTIVE_NOT_RECRUITING Phase NA
NCT05051358 Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study Status UNKNOWN Phase N/A
NCT05044312 Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis Status WITHDRAWN Phase NA
NCT05001347 A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors Status COMPLETED Phase PHASE2